Concepedia

Sergio Mucching‐Toscano

SM

3

Publications

59

Citations

3

H-Index

2023

Active since

Affiliations

EsSALUD(Current)

Université de Montpellier

Brigham and Women's Hospital

Sergio Mucching‐Toscano is an author at EsSALUD specializing in tuberculosis, clinical trials, and medicine.

Top concepts

HealthMedicinePharmacologyTuberculosisClinical TrialsDrug ResistancePharmacotherapyClinical MicrobiologyTuberculosis PreventionAntimicrobial Resistance

Publications per year

2023–2025

3

Publications

3

Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study

Joanitah Nalunjogi, Sergio Mucching‐Toscano, Jean Pierre Sibomana et al. · International Journal of Infectious Diseases · 2023 · 35 citations · Full text

Nine-month, all-oral regimens for rifampin-resistant tuberculosis

Lorenzo Guglielmetti, Uzma Khan, Gustavo E. Velásquez et al. · 2024 · 12 citations · Full text

Poor Treatments, Pulmonary Tuberculosis, Health Sciences +13

Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial

Lorenzo Guglielmetti, Uzma Khan, Gustavo E. Velásquez et al. · The Lancet Respiratory Medicine · 2025 · 12 citations · Full text

Rows per page

1–3 of 3